SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-13-163109
Filing Date
2013-04-19
Accepted
2013-04-19 17:27:49
Documents
8
Period of Report
2013-06-04

Document Format Files

Seq Description Document Type Size
1 PRE 14A d523596dpre14a.htm PRE 14A 1329520
2 GRAPHIC g523596g87f25.jpg GRAPHIC 8995
3 GRAPHIC g523596g90k08.jpg GRAPHIC 17883
4 GRAPHIC g523596pc_01d.jpg GRAPHIC 2947
5 GRAPHIC g523596pc_pg01a.jpg GRAPHIC 2957
6 GRAPHIC g523596pc_pg01b.jpg GRAPHIC 2265
7 GRAPHIC g523596pc_pg01c.jpg GRAPHIC 4653
8 GRAPHIC g523596sarepta_logo.jpg GRAPHIC 3856
  Complete submission text file 0001193125-13-163109.txt   1391906
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 617-444-8424
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-14895 | Film No.: 13772362
SIC: 2834 Pharmaceutical Preparations